Document is current
Any future updates will be listed below
-
Authors
Jesenak, Milos https://orcid.org/0000-0001-7976-2523
Prokopova, Elena
Bozensky, Jan
Bonaci-Nikolic, Branka
Milosevic, Katarina
Stankovic, Katarina
Ostojic, Olivera
Zivkovic, Zorica
Diamant, Zuzana https://orcid.org/0000-0003-0133-0100
Kunc, Peter
Janeczek, Kamil https://orcid.org/0000-0002-8163-873X
Majtan, Juraj https://orcid.org/0000-0002-7268-1584
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06974747 at ClinicalTrials.govDocuments that mention this clinical trial
Novel Chewable Pleuran-Based Supplement Decreases Respiratory Tract Infections in Children: A Randomised Controlled Trial
https://doi.org/10.1007/s12325-025-03393-3
-
Funding
Funding for this research was provided by:
Pleuran s.r.o. (-)
Slovak Academy of Sciences
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 29 September 2025
First Online: 14 October 2025
Declarations
:
: The authors (Milos Jesenak, Elena Prokopova, Jan Bozensky, Branka Bonaci-Nikolic, Katarina Milosevic, Katarina Stankovic, Olivera Ostojic, Zorica Zivkovic, Zuzana Diamant, Peter Kunc, Kamil Janeczek, Juraj Majtan) declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
: The study was conducted in accordance with legal and regulatory requirements and the ethical standards of the 1964 Declaration of Helsinki and its later amendments. The study protocol was reviewed and approved by local ethics committees in accordance with national regulations: the Bratislava Self-Governing Region (8658/2023/HF), the Trencin Self-Governing Region (TSC/2023/07875-2), the Banska Bystrica Self-Governing Region (14230/0DDZ/37796/2023), the Kosice Self-Governing Region (6396/2023/ODDZ-29243), Hospital Agel Ostrava-Vítkovice (EK/107/2023), and the Clinical Hospital Centre Dr Dragisa Mišović-Dedinje, Belgrade (20899/3-2023). Written informed consent was obtained from the participants’ parents or legal guardians prior to any study-related procedures. They were fully informed about the purpose, risks and benefits of the study, understood their voluntary role, and agreed to both participation of their children in the study and to the use and publication of their anonymised data. The study has been registered in ClinicalTrials.gov, ID NCT06974747.
